Evidence map›Paper›PMID 31209201›Full record

ArticleCell death & disease2019

BRCA2 deficiency is a potential driver for human primary ovarian insufficiency.

Yilong Miao, Pan Wang, Bingteng Xie, Mo Yang, Sen Li, Zhaokang Cui, Yong Fan, Mo Li, Bo Xiong

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04444245 (Re-establishment of Ovarian Hormonal Function, Delay of Menopause, or Reversal of Early Menopause With High Density), which is not on this map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04444245 phase1unknown statusnot on this mapstarted 2022, after this paper: background citation

Re-establishment of Ovarian Hormonal Function, Delay of Menopause, or Reversal of Early Menopause With High Density (HD PRP), tSVF + PRP, or Cell Enriched tSVF + PRP by Ultrasound Guided Ovarian Injection

TypeinterventionalSponsorBlack Tie Medical, Inc.Ran2022 to 2025Enrolled100ConditionsOvarian Failure, Perimenopausal Disorder, Hormone DisturbanceArmslipoaspiration harvest tSVF, Platelet Rich Plasma, Endovaginal Ultrasound, Cellular Isolation cSVF, Normal Saline (NS) .9% 10 mL Injection
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Yilong MiaoCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, China.
Pan WangCenter for Reproductive Medicine, Peking University Third Hospital, 100191, Beijing, China.
Bingteng XieCenter for Reproductive Medicine, Peking University Third Hospital, 100191, Beijing, China.
Mo YangCenter for Reproductive Medicine, Peking University Third Hospital, 100191, Beijing, China.
Sen LiReproductive Medicine Center, Guangdong Second Provincial General Hospital, 510317, Guangzhou, China.
Zhaokang CuiCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, China.
Yong FanKey Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, 510150, Guangzhou, China. fanyong0413@sina.com.
Mo LiCenter for Reproductive Medicine, Peking University Third Hospital, 100191, Beijing, China. limo@hsc.pku.edu.cn.
Bo XiongCollege of Animal Science and Technology, Nanjing Agricultural University, 210095, Nanjing, China. xiongbo@njau.edu.cn.
Nanjing Agricultural University · CNPeking University · CNPeking University Third Hospital · CNGuangdong Provincial People's Hospital · CNGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reproductive problem has been one of the top issues for women health worldwide in recent decades. As a typical female disease, primary ovarian insufficiency (POI) results in a loss of ovarian follicles and oocytes that thus destroys women fertility. However, due to the complex of POI etiology and rare resource of human POI oocytes, few biomarkers have been identified in clinics and no effective strategy could be applied to treat POI patients. In the search of possible association between DNA damage and POI by Smart-Seq2 and RT

Indexed as

AllelesAnimalsBRCA2 ProteinDNA DamageDown-RegulationExonsFemaleFertilityGene DeletionHumansMeiosisMiceOocytesOvarian FolliclePrimary Ovarian InsufficiencyBRCA2 ProteinBRCA2 protein, humanBRCA2 protein, mouse

Identifiers

PMID31209201
PMCPMC6572856
OpenAlexW2949858087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.